Fig. 1 · Structure
Documents & Downloads
JBC117
Anticancer Agent
JBC117 is a novel anticancer compound that targets the Pygo2 PHD domain. This agent effectively antagonizes β-catenin-dependent transcriptional activity, leading to the inhibition of cancer cell migration and invasion. Additionally, JBC117 induces apoptosis, making it a valuable tool for cancer research and therapeutic development.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 1214531-21-1 |
| Applications | Anticancer Agent |
| Formula | C28H30N2O3 |
| Molecular Weight | 442.55 |
| SMILES | OC(CN1CCC2(CC1)OC3=C(C(C2)O)C=CC4=C3C=CC=C4)C5=CNC6=C5C=CC(C)=C6 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.